Chapter/Section Purchase

1 Study Coverage
1.1 Subcutaneous Allergy Immunotherapies Product Introduction
1.2 Market by Type
1.2.1 Global Subcutaneous Allergy Immunotherapies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 High Concentration
1.2.3 Low Concentration
1.3 Market by Application
1.3.1 Global Subcutaneous Allergy Immunotherapies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Allergy Immunotherapies Sales Estimates and Forecasts 2017-2028
2.2 Global Subcutaneous Allergy Immunotherapies Revenue Estimates and Forecasts 2017-2028
2.3 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Subcutaneous Allergy Immunotherapies Sales by Region
2.4.1 Global Subcutaneous Allergy Immunotherapies Sales by Region (2017-2022)
2.4.2 Global Sales Subcutaneous Allergy Immunotherapies by Region (2023-2028)
2.5 Global Subcutaneous Allergy Immunotherapies Revenue by Region
2.5.1 Global Subcutaneous Allergy Immunotherapies Revenue by Region (2017-2022)
2.5.2 Global Subcutaneous Allergy Immunotherapies Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Subcutaneous Allergy Immunotherapies Sales by Manufacturers
3.1.1 Global Top Subcutaneous Allergy Immunotherapies Manufacturers by Sales (2017-2022)
3.1.2 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Subcutaneous Allergy Immunotherapies in 2021
3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturers
3.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Manufacturers (2017-2022)
3.2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Allergy Immunotherapies Revenue in 2021
3.3 Global Subcutaneous Allergy Immunotherapies Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Subcutaneous Allergy Immunotherapies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Subcutaneous Allergy Immunotherapies Sales by Type
4.1.1 Global Subcutaneous Allergy Immunotherapies Historical Sales by Type (2017-2022)
4.1.2 Global Subcutaneous Allergy Immunotherapies Forecasted Sales by Type (2023-2028)
4.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2017-2028)
4.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type
4.2.1 Global Subcutaneous Allergy Immunotherapies Historical Revenue by Type (2017-2022)
4.2.2 Global Subcutaneous Allergy Immunotherapies Forecasted Revenue by Type (2023-2028)
4.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2017-2028)
4.3 Global Subcutaneous Allergy Immunotherapies Price by Type
4.3.1 Global Subcutaneous Allergy Immunotherapies Price by Type (2017-2022)
4.3.2 Global Subcutaneous Allergy Immunotherapies Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Subcutaneous Allergy Immunotherapies Sales by Application
5.1.1 Global Subcutaneous Allergy Immunotherapies Historical Sales by Application (2017-2022)
5.1.2 Global Subcutaneous Allergy Immunotherapies Forecasted Sales by Application (2023-2028)
5.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2017-2028)
5.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application
5.2.1 Global Subcutaneous Allergy Immunotherapies Historical Revenue by Application (2017-2022)
5.2.2 Global Subcutaneous Allergy Immunotherapies Forecasted Revenue by Application (2023-2028)
5.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2017-2028)
5.3 Global Subcutaneous Allergy Immunotherapies Price by Application
5.3.1 Global Subcutaneous Allergy Immunotherapies Price by Application (2017-2022)
5.3.2 Global Subcutaneous Allergy Immunotherapies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Subcutaneous Allergy Immunotherapies Market Size by Type
6.1.1 North America Subcutaneous Allergy Immunotherapies Sales by Type (2017-2028)
6.1.2 North America Subcutaneous Allergy Immunotherapies Revenue by Type (2017-2028)
6.2 North America Subcutaneous Allergy Immunotherapies Market Size by Application
6.2.1 North America Subcutaneous Allergy Immunotherapies Sales by Application (2017-2028)
6.2.2 North America Subcutaneous Allergy Immunotherapies Revenue by Application (2017-2028)
6.3 North America Subcutaneous Allergy Immunotherapies Market Size by Country
6.3.1 North America Subcutaneous Allergy Immunotherapies Sales by Country (2017-2028)
6.3.2 North America Subcutaneous Allergy Immunotherapies Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Subcutaneous Allergy Immunotherapies Market Size by Type
7.1.1 Europe Subcutaneous Allergy Immunotherapies Sales by Type (2017-2028)
7.1.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Type (2017-2028)
7.2 Europe Subcutaneous Allergy Immunotherapies Market Size by Application
7.2.1 Europe Subcutaneous Allergy Immunotherapies Sales by Application (2017-2028)
7.2.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Application (2017-2028)
7.3 Europe Subcutaneous Allergy Immunotherapies Market Size by Country
7.3.1 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2017-2028)
7.3.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Type
8.1.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Type (2017-2028)
8.1.2 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Type (2017-2028)
8.2 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Application
8.2.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Application (2017-2028)
8.2.2 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Application (2017-2028)
8.3 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Region
8.3.1 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2017-2028)
8.3.2 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Subcutaneous Allergy Immunotherapies Market Size by Type
9.1.1 Latin America Subcutaneous Allergy Immunotherapies Sales by Type (2017-2028)
9.1.2 Latin America Subcutaneous Allergy Immunotherapies Revenue by Type (2017-2028)
9.2 Latin America Subcutaneous Allergy Immunotherapies Market Size by Application
9.2.1 Latin America Subcutaneous Allergy Immunotherapies Sales by Application (2017-2028)
9.2.2 Latin America Subcutaneous Allergy Immunotherapies Revenue by Application (2017-2028)
9.3 Latin America Subcutaneous Allergy Immunotherapies Market Size by Country
9.3.1 Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2017-2028)
9.3.2 Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Type
10.1.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Type (2017-2028)
10.1.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Type (2017-2028)
10.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Application
10.2.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Application (2017-2028)
10.2.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Application (2017-2028)
10.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country
10.3.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2017-2028)
10.3.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ALK-Abello
11.1.1 ALK-Abello Corporation Information
11.1.2 ALK-Abello Overview
11.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ALK-Abello Recent Developments
11.2 Stallergenes Greer
11.2.1 Stallergenes Greer Corporation Information
11.2.2 Stallergenes Greer Overview
11.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Stallergenes Greer Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Corporation Information
11.4.2 Allergy Therapeutics Overview
11.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Allergy Therapeutics Recent Developments
11.5 HAL
11.5.1 HAL Corporation Information
11.5.2 HAL Overview
11.5.3 HAL Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 HAL Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HAL Recent Developments
11.6 WOLW Pharma
11.6.1 WOLW Pharma Corporation Information
11.6.2 WOLW Pharma Overview
11.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 WOLW Pharma Recent Developments
11.7 Holister Stier
11.7.1 Holister Stier Corporation Information
11.7.2 Holister Stier Overview
11.7.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Holister Stier Recent Developments
11.8 Leti
11.8.1 Leti Corporation Information
11.8.2 Leti Overview
11.8.3 Leti Subcutaneous Allergy Immunotherapies Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Leti Subcutaneous Allergy Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Leti Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Subcutaneous Allergy Immunotherapies Industry Chain Analysis
12.2 Subcutaneous Allergy Immunotherapies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Subcutaneous Allergy Immunotherapies Production Mode & Process
12.4 Subcutaneous Allergy Immunotherapies Sales and Marketing
12.4.1 Subcutaneous Allergy Immunotherapies Sales Channels
12.4.2 Subcutaneous Allergy Immunotherapies Distributors
12.5 Subcutaneous Allergy Immunotherapies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Subcutaneous Allergy Immunotherapies Industry Trends
13.2 Subcutaneous Allergy Immunotherapies Market Drivers
13.3 Subcutaneous Allergy Immunotherapies Market Challenges
13.4 Subcutaneous Allergy Immunotherapies Market Restraints
14 Key Findings in The Global Subcutaneous Allergy Immunotherapies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer